Johnson & Johnson applies for emergency COVID-19 vaccine use in the Philippines

In this photo illustration a Johnson & Johnson logo is seen in front of a medical syringe and a vial with coronavirus vaccine. Pavlo Gonchar/SOPA Images/LightRocket/Getty Images
UKRAINE – 2021/02/05: In this photo illustration a Johnson & Johnson logo is seen in front of a medical syringe and a vial with coronavirus vaccine.
Johnson & Johnson (J&J) has asked regulators to authorize their COVID-19 vaccine for emergency use in the U.S. and also will apply to authorize to EU, reportedly by media. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images)

Drugmaker Johnson & Johnson has filed its application for emergency use authorization of its COVID-19 vaccine in the Philippines, the country’s Food and Drug Administration (FDA) chief said on Monday.

J&J’s documents, which were submitted on Wednesday, are now under evaluation, FDA Director-General Rolando Enrique Domingo told reporters. J&J, which has a single-shot coronavirus vaccine, is the seventh vaccine maker to seek approval in the Philippines